Australia Stock Exchange release from PHARMAUST : Epichem Awarded Contract Extension from DNDi
14/12/2021 22:11
Australia Stock Exchange release from PHARMAUST PAA.AX : Epichem Awarded Contract Extension from DNDi
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility